Financhill
Back

Novavax Stock Predictions

Novavax Stock Forecast

  • Over the next 52 weeks, Novavax has on average historically risen by 61.1% based on the past 29 years of stock performance.
  • Novavax has risen higher in 14 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.28%
  • Is Novavax Stock Undervalued?
    The current Novavax [NVAX] share price is $6.33. The Score for NVAX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NVAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Novavax Stock Go Up Next Year?

  • Over the next 52 weeks, Novavax has on average historically risen by 61.1% based on the past 29 years of stock performance.

Novavax Stock Rating

Sell
28
Novavax (NVAX) is a Sell

Is Novavax overpriced?

  • Novavax has risen higher in 14 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.28%

Novavax Stock Price History

Is NVAX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVAX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
novavax.com

52-Week Data

52-Week High:
23.86
52-Week Low:
3.81

Prediction Charts

Market Cap:
1B
Price in USD:
6.33
Volume:
5.5M
Beta:
1.67

Technical Analysis

SMA50:
7.81
SMA100:
8.23
SMA200:
10.36
52-Wk Change:
42.89%

Stock Predictions

  • Is Novavax stock public?
    Yes, Novavax is a publicly traded company.
  • What is the Novavax stock quote today?
    The Novavax stock price is 6.33 USD today.
  • How to buy Novavax stock online?
    You can buy Novavax shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-20 7.81 7.72 7.91 7.65
Mar-21 7.58 7.61 7.66 7.47
Mar-24 7.62 7.69 7.81 7.58
Mar-25 7.68 7.56 7.72 7.48
Mar-26 7.56 7.39 7.57 7.25
Mar-27 7.36 7.26 7.42 7.24
Mar-28 7.24 7.00 7.29 6.93
Mar-31 6.49 6.41 6.59 6.28
Apr-1 6.41 6.00 6.43 6.00
Apr-2 5.90 5.98 6.23 5.70
Apr-3 5.58 5.60 5.83 5.35
Apr-4 5.40 6.24 6.32 5.33
Apr-7 5.83 6.54 6.61 5.78
Apr-8 6.80 6.33 6.84 6.08

Novavax Earnings

Novavax Earnings Report: Per Share Novavax Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novavax Forecast Revenue Growth

Novavax Stock Analysis: Historical quarterly revenues per share for Novavax and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.42 per share, an increase next quarter of $0.54 per share, an increase this year of $1.41 per share, and an increase next year of $0.28 per share.

* Novavax stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.